Tools to Alleviate the Drug Resistance in Mycobacterium tuberculosis.
| Title: | Tools to Alleviate the Drug Resistance in Mycobacterium tuberculosis. |
|---|---|
| Authors: | Rabaan AA; Molecular Diagnostic Laboratory, Johns Hopkins Aramco Healthcare, Dhahran 31311, Saudi Arabia.; College of Medicine, Alfaisal University, Riyadh 11533, Saudi Arabia.; Department of Public Health and Nutrition, The University of Haripur, Haripur 22610, Pakistan.; Mutair AA; Research Center, Almoosa Specialist Hospital, Al-Ahsa 36342, Saudi Arabia.; College of Nursing, Princess Norah bint Abdulrahman University, Riyadh 11564, Saudi Arabia.; School of Nursing, Wollongong University, Wollongong, NSW 2522, Australia.; Nursing Department, Prince Sultan Military College of Health Sciences, Dhahran 33048, Saudi Arabia.; Albayat H; Infectious Disease Department, King Saud Medical City, Riyadh 7790, Saudi Arabia.; Alotaibi J; Infectious Diseases Unit, Department of Medicine, King Faisal Specialist Hospital and Research Center, Riyadh 11564, Saudi Arabia.; Sulaiman T; Infectious Diseases Section, Medical Specialties Department, King Fahad Medical City, Riyadh 12231, Saudi Arabia.; Aljeldah M; Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, University of Hafr Al Batin, Hafr Al Batin 39831, Saudi Arabia.; Shammari BRA; Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, University of Hafr Al Batin, Hafr Al Batin 39831, Saudi Arabia.; Alfaraj AH; Pediatric Department, Abqaiq General Hospital, First Eastern Health Cluster, Abqaiq 33261, Saudi Arabia.; Al Fares MA; Department of Internal Medicine, King Abdulaziz University Hospital, Jeddah 21589, Saudi Arabia.; Alwarthan S; Department of Internal Medicine, College of Medicine, Imam Abdulrahman Bin Faisal University, Dammam 34212, Saudi Arabia.; Binjomah AZ; Microbiology Department, Riyadh Regional Laboratory and Blood Bank, Riyadh 12746, Saudi Arabia.; Alzahrani MS; Department of Infectious Diseases, King Abdulaziz Medical City, Ministry of National Guard Health Affairs, Jeddah 21423, Saudi Arabia.; Infectious Disease Department, King Saud Bin Abdulaziz University for Health Sciences, Jeddah 21423, Saudi Arabia.; Alhani HM; Department of Pediatric Infectious Disease, Maternity and Children Hospital, Dammam 31176, Saudi Arabia.; Department of Infection Control, Maternity and Children Hospital, Dammam 31176, Saudi Arabia.; Preventive Medicine and Infection Prevention and Control Department, Directorate of Ministry of Health, Dammam 32245, Saudi Arabia.; Almogbel MS; Department of Medical Laboratory Sciences, College of Applied Medical Sciences, University of Hail, Hail 4030, Saudi Arabia.; Abuzaid AA; Medical Microbiology Department, Security Forces Hospital Programme, Dammam 32314, Saudi Arabia.; Alqurainees G; Pediatrics Department, Prince Mohammed Bin Abdulaziz Hospital, Ministry of National Guard Health Affairs, Medina 41511, Saudi Arabia.; Al Ibrahim F; Infectious Disease Division, Department of Internal Medicine, Dammam Medical Complex, Dammam 32245, Saudi Arabia.; Alhaddad AH; Assistant Agency for Hospital Affairs, Ministry of Health, Riyadh 12382, Saudi Arabia.; Alfaresi M; Department of Pathology and Laboratory Medicine, Sheikh Khalifa General Hospital, Umm Al Quwain 499, United Arab Emirates.; Department of Pathology, College of Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai 505055, United Arab Emirates.; Al-Baghli N; Directorate of Public Health, Dammam Network, Eastern Health Cluster, Dammam 31444, Saudi Arabia.; Alhumaid S; Administration of Pharmaceutical Care, Al-Ahsa Health Cluster, Ministry of Health, Al-Ahsa 31982, Saudi Arabia. |
| Source: | Molecules (Basel, Switzerland) [Molecules] 2022 Oct 17; Vol. 27 (20). Date of Electronic Publication: 2022 Oct 17. |
| Publication Type: | Journal Article; Review |
| Language: | English |
| Journal Info: | Publisher: MDPI Country of Publication: Switzerland NLM ID: 100964009 Publication Model: Electronic Cited Medium: Internet ISSN: 1420-3049 (Electronic) Linking ISSN: 14203049 NLM ISO Abbreviation: Molecules Subsets: MEDLINE |
| Imprint Name(s): | Original Publication: Basel, Switzerland : MDPI, c1995- |
| MeSH Terms: | Tuberculosis*/drug therapy ; Tuberculosis*/epidemiology ; Tuberculosis*/microbiology ; Mycobacterium tuberculosis* ; COVID-19* ; Nucleic Acids*; Antitubercular Agents/pharmacology ; Antitubercular Agents/therapeutic use ; Humans ; Pandemics ; Drug Resistance ; Drug Resistance, Multiple, Bacterial ; Microbial Sensitivity Tests |
| Abstract: | Mycobacterium tuberculosis (Mtb), an acid-fast bacillus that causes Tuberculosis (TB), is a pathogen that caused 1.5 million deaths in 2020. As per WHO estimates, another 4.1 million people are suffering from latent TB, either asymptomatic or not diagnosed, and the frequency of drug resistance is increasing due to intrinsically linked factors from both host and bacterium. For instance, poor access to TB diagnosis and reduced treatment in the era of the COVID-19 pandemic has resulted in more TB deaths and an 18% reduction in newly diagnosed cases of TB. Additionally, the detection of Mtb isolates exhibiting resistance to multiple drugs (MDR, XDR, and TDR) has complicated the scenario in the pathogen's favour. Moreover, the conventional methods to detect drug resistance may miss mutations, making it challenging to decide on the treatment regimen. However, owing to collaborative initiatives, the last two decades have witnessed several advancements in both the detection methods and drug discovery against drug-resistant isolates. The majority of them belong to nucleic acid detection techniques. In this review, we highlight and summarize the molecular mechanism underlying drug resistance in Mtb, the recent advancements in resistance detection methods, and the newer drugs used against drug-resistant TB. |
| References: | J Clin Microbiol. 2010 Jan;48(1):229-37. (PMID: 19864480); J Clin Microbiol. 2001 Jul;39(7):2642-5. (PMID: 11427584); Int J Tuberc Lung Dis. 2021 Apr 1;25(4):305-314. (PMID: 33762075); J Antimicrob Chemother. 1999 May;43(5):615-23. (PMID: 10382882); Nucleic Acids Res. 2000 Jun 15;28(12):E63. (PMID: 10871386); Antimicrob Agents Chemother. 2011 Jan;55(1):355-60. (PMID: 20974869); Clin Microbiol Infect. 2022 May;28(5):731.e9-731.e15. (PMID: 34600118); FEMS Microbiol Rev. 2017 May 1;41(3):354-373. (PMID: 28369307); Trends Genet. 2011 Aug;27(8):323-31. (PMID: 21684621); Nature. 1957 May 18;179(4568):1013-5. (PMID: 13430770); J Infect Dev Ctries. 2010 Nov 24;4(11):695-703. (PMID: 21252446); J Health Popul Nutr. 2011 Feb;29(1):20-5. (PMID: 21528787); Eur Respir J. 2013 Jun;41(6):1393-400. (PMID: 23018916); Int J Tuberc Lung Dis. 2002 Dec;6(12):1118-22. (PMID: 12546122); J Clin Microbiol. 1998 May;36(5):1220-5. (PMID: 9574680); Clin Infect Dis. 1998 Feb;26(2):446-50. (PMID: 9502469); Antimicrob Agents Chemother. 2018 Jan 25;62(2):. (PMID: 29203492); Antimicrob Agents Chemother. 1992 Dec;36(12):2729-35. (PMID: 1482140); Lancet. 2015 May 2;385(9979):1799-1801. (PMID: 25814376); Front Cell Infect Microbiol. 2018 Apr 10;8:114. (PMID: 29755957); Int J Infect Dis. 2019 Aug;85:74-79. (PMID: 31100421); J Clin Microbiol. 2001 Feb;39(2):651-7. (PMID: 11158124); Drugs. 2015 Jan;75(1):91-100. (PMID: 25404020); Methods Mol Med. 2001;54:145-54. (PMID: 21341074); Bioinformatics. 2018 May 15;34(10):1666-1671. (PMID: 29240876); Arch Pathol Lab Med. 1997 Aug;121(8):859-64. (PMID: 9278615); Eur Respir J. 2017 May 21;49(5):. (PMID: 28529205); Nucleic Acids Res. 2013 Feb 1;41(4):2370-81. (PMID: 23275532); Antimicrob Agents Chemother. 2003 Dec;47(12):3799-805. (PMID: 14638486); Tuber Lung Dis. 1999;79(3):153-69. (PMID: 10656114); mSphere. 2021 Jan 6;6(1):. (PMID: 33408221); J Clin Microbiol. 1999 Oct;37(10):3179-86. (PMID: 10488174); J Clin Microbiol. 2003 Sep;41(9):4471-4. (PMID: 12958298); PLoS Genet. 2009 Jul;5(7):e1000578. (PMID: 19629166); Int J Nanomedicine. 2015 Mar 04;10:1743-57. (PMID: 25784802); J Clin Microbiol. 1995 Dec;33(12):3225-33. (PMID: 8586707); Int J Tuberc Lung Dis. 2009 Nov;13(11):1320-30. (PMID: 19861002); Chemotherapy. 2000 Jan-Feb;46(1):43-8. (PMID: 10601797); J Microbiol Methods. 2011 Feb;84(2):155-60. (PMID: 21129417); Clin Microbiol Infect. 2018 Apr;24(4):355-360. (PMID: 29117578); J Antimicrob Chemother. 2007 Feb;59(2):175-83. (PMID: 17135182); J Clin Microbiol. 2009 Aug;47(8):2520-4. (PMID: 19494067); J Med Microbiol. 2006 Nov;55(Pt 11):1527-1531. (PMID: 17030912); Nat Genet. 2013 Oct;45(10):1255-60. (PMID: 23995137); Antimicrob Agents Chemother. 2013 Apr;57(4):1648-53. (PMID: 23335744); Clin Microbiol Infect. 2010 Apr;16(4):396-9. (PMID: 19486070); Science. 1996 Jun 14;272(5268):1641-3. (PMID: 8658136); Science. 1998 Jun 5;280(5369):1607-10. (PMID: 9616124); Mol Microbiol. 1993 Nov;10(3):521-7. (PMID: 7968530); Int J Tuberc Lung Dis. 1999 Feb;3(2):138-42. (PMID: 10091879); J Appl Microbiol. 2010 Dec;109(6):2087-94. (PMID: 20854453); Cell Mol Immunol. 2020 Sep;17(9):901-913. (PMID: 32728204); Am J Respir Crit Care Med. 2016 Sep 1;194(5):621-30. (PMID: 26910495); J Biol Chem. 2011 Mar 25;286(12):10276-87. (PMID: 21193400); J Clin Microbiol. 2006 Jun;44(6):1925-9. (PMID: 16757581); Nucleic Acids Res. 2014 Jan;42(Database issue):D1091-7. (PMID: 24203711); Nat Genet. 2011 Dec 18;44(1):106-10. (PMID: 22179134); Antimicrob Agents Chemother. 2003 Apr;47(4):1241-50. (PMID: 12654653); Science. 2005 Jun 3;308(5727):1480-3. (PMID: 15933203); Proc Natl Acad Sci U S A. 2009 Nov 24;106(47):20004-9. (PMID: 19906990); Mol Microbiol. 2007 Feb;63(4):1096-106. (PMID: 17238915); J Antimicrob Chemother. 2009 Jun;63(6):1173-8. (PMID: 19329799); Antimicrob Agents Chemother. 2001 Jul;45(7):2157-9. (PMID: 11408244); Antimicrob Agents Chemother. 2002 May;46(5):1417-24. (PMID: 11959577); Tuber Lung Dis. 1998;79(1):3-29. (PMID: 10645439); Eur Respir J. 2017 Jul 27;50(1):. (PMID: 28751415); Clin Microbiol Infect. 2018 Apr;24(4):335-341. (PMID: 29074157); Int J Tuberc Lung Dis. 2006 Sep;10(9):1057-9. (PMID: 16964801); J Clin Biochem Nutr. 2008 May;42(3):228-34. (PMID: 18545645); Sci Rep. 2020 Mar 26;10(1):5487. (PMID: 32218465); Nature. 2009 Apr 30;458(7242):1180-4. (PMID: 19407801); J Clin Microbiol. 2007 Jun;45(6):1936-40. (PMID: 17392443); Am J Respir Crit Care Med. 2015 Apr 15;191(8):943-53. (PMID: 25622149); J Immunol Methods. 1983 Dec 16;65(1-2):55-63. (PMID: 6606682); Int J Tuberc Lung Dis. 1998 Sep;2(9):751-5. (PMID: 9755930); Antimicrob Agents Chemother. 1994 Apr;38(4):805-11. (PMID: 8031050); Trop Med Int Health. 2010 Sep;15(9):1052-66. (PMID: 20545927); Antimicrob Agents Chemother. 2015 Aug;59(8):4457-63. (PMID: 25987624); Arch Toxicol. 2016 Jul;90(7):1585-604. (PMID: 27161440); Int J Antimicrob Agents. 2008 May;31(5):498-500. (PMID: 18313272); J Med Microbiol. 2003 Jul;52(Pt 7):557-561. (PMID: 12808076); Biochemistry. 2007 Oct 30;46(43):11998-2004. (PMID: 17915954); PLoS One. 2014 Dec 10;9(12):e112213. (PMID: 25494360); Microbiol Spectr. 2014 Aug;2(4):MGM2-0014-2013. (PMID: 26104204); Int J Tuberc Lung Dis. 2011 Mar;15(3):344-51. (PMID: 21333101); J Clin Microbiol. 2006 Jul;44(7):2378-81. (PMID: 16825352); Folia Med (Plovdiv). 2020 Sep 30;62(3):444-452. (PMID: 33009738); Methods Mol Med. 2001;54:155-64. (PMID: 21341075); J Clin Lab Anal. 2013 Jan;27(1):31-7. (PMID: 23325741); Proc Natl Acad Sci U S A. 2013 Jul 2;110(27):E2510-7. (PMID: 23776209); Antimicrob Agents Chemother. 1995 Mar;39(3):694-701. (PMID: 7793875); Evolution. 2011 Aug;65(8):2370-9. (PMID: 21790582); J Antimicrob Chemother. 2006 May;57(5):825-31. (PMID: 16547071); Trans R Soc Trop Med Hyg. 2016 Mar;110(3):163-72. (PMID: 26884496); J Microbiol Methods. 2008 Oct;75(2):161-6. (PMID: 18627779); Front Microbiol. 2019 Feb 19;10:216. (PMID: 30837962); Nat Commun. 2012 Mar 20;3:753. (PMID: 22434196); Proc Natl Acad Sci U S A. 1998 Mar 31;95(7):3949-53. (PMID: 9520473); J Clin Microbiol. 1983 Sep;18(3):689-96. (PMID: 6195181); Immunol Rev. 2015 Mar;264(1):6-24. (PMID: 25703549); Int J Tuberc Lung Dis. 2006 Jan;10(1):68-73. (PMID: 16466040); J Clin Microbiol. 2005 Nov;43(11):5477-82. (PMID: 16272473); Lancet. 2018 Sep 8;392(10150):821-834. (PMID: 30215381); Int J Mycobacteriol. 2015 Sep;4(3):202-6. (PMID: 27649867); Nat Med. 1996 Jun;2(6):662-7. (PMID: 8640557); J Antimicrob Chemother. 2018 May 1;73(5):1138-1151. (PMID: 29360989); J Clin Microbiol. 1996 Aug;34(8):2007-10. (PMID: 8818900); Carbohydr Res. 2011 Sep 6;346(12):1490-4. (PMID: 21546004); J Clin Microbiol. 1998 May;36(5):1214-9. (PMID: 9574679); EXCLI J. 2017 Mar 07;16:210-228. (PMID: 28507467); Biochemistry. 2012 Jun 19;51(24):4959-67. (PMID: 22646013); J Antimicrob Chemother. 2011 Jul;66(7):1417-30. (PMID: 21558086); BMC Infect Dis. 2014;14 Suppl 1:S5. (PMID: 24564453); Tuberc Res Treat. 2017;2017:4920209. (PMID: 28210505); Clin Microbiol Infect. 2005 Jul;11(7):531-9. (PMID: 15966970); J Clin Microbiol. 2001 Nov;39(11):4184-6. (PMID: 11682556); Lett Appl Microbiol. 2002;35(4):267-71. (PMID: 12358685); J Clin Microbiol. 2002 Feb;40(2):553-5. (PMID: 11825971); Tuber Lung Dis. 2000;80(1):47-56. (PMID: 10897383); Int J Tuberc Lung Dis. 2013 Aug;17(8):1001-7. (PMID: 23541151); Antimicrob Agents Chemother. 2006 Aug;50(8):2640-9. (PMID: 16870753); Nat Med. 1997 Apr;3(4):465-8. (PMID: 9095184); J Microbiol Methods. 2005 Nov;63(2):165-72. (PMID: 15893392); J Clin Microbiol. 2009 Jun;47(6):1767-72. (PMID: 19386845); J Biol Chem. 2001 Dec 28;276(52):48854-62. (PMID: 11677227); Antibiotics (Basel). 2014 Jul 02;3(3):317-40. (PMID: 27025748); Diagn Microbiol Infect Dis. 2005 Nov;53(3):201-8. (PMID: 16243477); J Antimicrob Chemother. 2010 May;65(5):897-900. (PMID: 20185419); Antimicrob Agents Chemother. 2000 Feb;44(2):326-36. (PMID: 10639358); J Med Microbiol. 2003 Nov;52(Pt 11):999-1003. (PMID: 14532345); J Antimicrob Chemother. 2014 Feb;69(2):292-302. (PMID: 24072169); Emerg Microbes Infect. 2014 Mar;3(3):e17. (PMID: 26038512); J Bacteriol. 2002 Apr;184(8):2167-72. (PMID: 11914348); Lancet Infect Dis. 2010 Sep;10(9):621-9. (PMID: 20797644); Future Med Chem. 2013 Jul;5(11):1285-309. (PMID: 23859208); Drug Resist Updat. 2010 Dec;13(6):151-71. (PMID: 20833577); Crit Rev Biochem Mol Biol. 1991;26(3-4):335-75. (PMID: 1657531); Annu Rev Microbiol. 2010;64:293-311. (PMID: 20825351); Microbiol Spectr. 2016 Apr;4(2):. (PMID: 27227291); Mol Microbiol. 2001 May;40(4):879-89. (PMID: 11401695); Chembiochem. 2013 Nov 4;14(16):2127-35. (PMID: 24106131); Curr Opin Immunol. 2015 Aug;35:55-62. (PMID: 26113434); Antimicrob Agents Chemother. 1999 Aug;43(8):2087-9. (PMID: 10428945); Int J Mycobacteriol. 2016 Mar;5(1):1-6. (PMID: 26927983); J Antimicrob Chemother. 2009 Oct;64(4):694-701. (PMID: 19710078); Tuberculosis (Edinb). 2007 May;87(3):193-201. (PMID: 17029964); Microb Drug Resist. 2006 Spring;12(1):7-11. (PMID: 16584301); J Mol Biol. 2002 Jul 5;320(2):249-61. (PMID: 12079383); Mem Inst Oswaldo Cruz. 2007 Feb;102(1):59-61. (PMID: 17294000); Proc Natl Acad Sci U S A. 2000 Aug 15;97(17):9677-82. (PMID: 10944230); Antimicrob Agents Chemother. 2010 Sep;54(9):3776-82. (PMID: 20566771); BMC Med. 2015 Jun 05;13:135. (PMID: 26048371); Bioconjug Chem. 2008 Apr;19(4):840-8. (PMID: 18376856); Eur J Clin Microbiol Infect Dis. 1999 May;18(5):380-3. (PMID: 10421050); Nat Med. 1997 May;3(5):567-70. (PMID: 9142129); J Clin Microbiol. 1997 May;35(5):1287-9. (PMID: 9114429); Pharmaceuticals (Basel). 2012 Nov 09;5(11):1210-35. (PMID: 24281307); Antimicrob Agents Chemother. 2010 Mar;54(3):1075-81. (PMID: 20008778); Antimicrob Agents Chemother. 1989 Sep;33(9):1493-9. (PMID: 2817850); Eur Respir J. 2015 Oct;46(4):887-93. (PMID: 26424519); Curr Top Med Chem. 2009;9(11):981-98. (PMID: 19747119); Lancet Infect Dis. 2004 Sep;4(9):584-92. (PMID: 15336226); Future Microbiol. 2011 Sep;6(9):1067-82. (PMID: 21958145); J Appl Microbiol. 2020 Jun;128(6):1547-1567. (PMID: 31595643); J Evol Biol. 2009 May;22(5):997-1003. (PMID: 19298493); J Clin Microbiol. 1997 Jan;35(1):121-4. (PMID: 8968892); Antimicrob Agents Chemother. 2004 Sep;48(9):3373-81. (PMID: 15328099); J Antimicrob Chemother. 2007 May;59(5):866-73. (PMID: 17360809); J Clin Microbiol. 1995 Sep;33(9):2324-7. (PMID: 7494021); Antimicrob Agents Chemother. 2005 Jan;49(1):144-7. (PMID: 15616288); Antimicrob Resist Infect Control. 2019 May 2;8:70. (PMID: 31073401); Emerg Infect Dis. 1998 Apr-Jun;4(2):195-209. (PMID: 9621190); Life Sci. 2021 Feb 1;266:118851. (PMID: 33310032); J Clin Microbiol. 2009 Dec;47(12):3985-90. (PMID: 19846642); N Engl J Med. 2006 Oct 12;355(15):1539-50. (PMID: 17035648); Diagn Microbiol Infect Dis. 2012 Jan;72(1):52-61. (PMID: 22078903); Infect Drug Resist. 2017 Oct 13;10:333-342. (PMID: 29075131); Expert Rev Anti Infect Ther. 2016 Oct;14(10):901-15. (PMID: 27532292); Chest. 2009 Aug;136(2):420-425. (PMID: 19349380); Antimicrob Agents Chemother. 2008 Aug;52(8):2947-9. (PMID: 18541729); Clin Microbiol Infect. 2019 Aug;25(8):1041.e1-1041.e7. (PMID: 30583053); Future Microbiol. 2008 Apr;3(2):111-3. (PMID: 18366328); Curr Issues Mol Biol. 2005 Jan;7(1):7-21. (PMID: 15580777); Artif Cells Nanomed Biotechnol. 2019 Dec;47(1):427-435. (PMID: 30672352); Expert Rev Respir Med. 2009 Oct;3(5):497-510. (PMID: 20477339); Antimicrob Agents Chemother. 1993 Oct;37(10):2054-8. (PMID: 8257122); PLoS One. 2015 Mar 23;10(3):e0119628. (PMID: 25799046); Nature. 2000 Sep 21;407(6802):340-8. (PMID: 11014183); J Infect Dis. 1998 Sep;178(3):769-75. (PMID: 9728546); Int J Mycobacteriol. 2017 Apr-Jun;6(2):177-183. (PMID: 28559521); Front Microbiol. 2018 Sep 12;9:2179. (PMID: 30258428); Respir Res. 2001;2(3):164-8. (PMID: 11686881); J Antimicrob Chemother. 2017 Jun 1;72(6):1678-1687. (PMID: 28333192); Int J Infect Dis. 2022 Mar 20;:. (PMID: 35321845); Proc Natl Acad Sci U S A. 1994 Mar 15;91(6):2091-4. (PMID: 8134354); J Clin Microbiol. 2006 Oct;44(10):3659-64. (PMID: 17021094); Antimicrob Agents Chemother. 1997 Aug;41(8):1677-81. (PMID: 9257740); BMC Infect Dis. 2010 Jun 03;10:149. (PMID: 20525271); Bull Exp Biol Med. 2008 Jan;145(1):108-13. (PMID: 19024017); J Glob Antimicrob Resist. 2018 Mar;12:192-196. (PMID: 29042338); J Clin Microbiol. 2005 Aug;43(8):3699-703. (PMID: 16081898); Antimicrob Agents Chemother. 1996 May;40(5):1186-8. (PMID: 8723463); Int J Tuberc Lung Dis. 2005 Mar;9(3):328-32. (PMID: 15786899); Lung India. 2011 Jul;28(3):193-200. (PMID: 21886955) |
| Contributed Indexing: | Keywords: Mycobacterium tuberculosis; antibiotics; drug resistance; mutations |
| Substance Nomenclature: | 0 (Antitubercular Agents); 0 (Nucleic Acids) |
| Entry Date(s): | Date Created: 20221027 Date Completed: 20221028 Latest Revision: 20221030 |
| Update Code: | 20260130 |
| PubMed Central ID: | PMC9606950 |
| DOI: | 10.3390/molecules27206985 |
| PMID: | 36296578 |
| Database: | MEDLINE |
Journal Article; Review